BARRITAULT DENIS has a total of 23 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and organic fine chemistry are PHARMABRAND S A, PSYADON PHARMACEUTICALS INC and DERMAN BIOMEDICINE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | France | 4 | |
#5 | Canada | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides | |
#4 | Special macromolecular compounds | |
#5 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Barritault Denis | 23 |
#2 | Caruelle Jean-Pierre | 9 |
#3 | Caruelle Jean Pierre | 4 |
#4 | Barbier-Chassefiere Veronique | 4 |
#5 | Bernaudin Myriam | 2 |
#6 | Touzani Omar | 2 |
#7 | Toutain Jérôme | 2 |
#8 | Quittet Marie-Sophie | 2 |
Publication | Filing date | Title |
---|---|---|
EP3097922A1 | Composition for the treatment of tissue lesions | |
US2007141020A1 | Use of biocompatible polymers for the preparation of a composition or a medical device | |
FR2781376A1 | Protective and regulatory composition of bone mass homeostasis containing polymers or biopolymers and uses thereof | |
FR2781374A1 | Antioxidant composition comprising at least one polymer or biopolymer alone or associated with sod | |
FR2781485A1 | Biocompatible polymers, process for their preparation and compositions containing them | |
FR2781375A1 | Use of (bio)polymer of heparin-binding growth factor protector and potentiator family to prepare medicament for treating and/or preventing fibrosis |